President Biden recently invoked the Defense Production Act to support investment in domestic drug manufacturing. It’s part of Bidenomics and is designed to bolster supply chains and increase spending at home.

What’s the strategy here? And will it work?

TOPICS
(01:08) Defense Production Act
(02:04) Using DPA in healthcare
(03:20) Criticism of DPA
(05:14) US drug costs
(07:30) Drug shortages explained
(08:19) Outsourcing drug production
(10:30) Will DPA solve shortages?
(13:19) DPA's blunt force
(18:24) Strategic stockpiles

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

GET IN TOUCH
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter
Shop official CareTalk merch

FOLLOW CARETALK
Spotify
Apple Podcasts
Google Podcasts
Follow us on LinkedIn

#healthcare #healthcarepolicy #healthcarebusiness #healthcaretechnology  #healthinsurance #drugshortages #dpa #defenseproductionact


Support the Show.


CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing